1. Home
  2. SHEN vs YDES Comparison

SHEN vs YDES Comparison

Compare SHEN & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shenandoah Telecommunications Co

SHEN

Shenandoah Telecommunications Co

HOLD

Current Price

$13.26

Market Cap

635.1M

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.53

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHEN
YDES
Founded
1902
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
635.1M
543.0M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
SHEN
YDES
Price
$13.26
$2.53
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$26.00
N/A
AVG Volume (30 Days)
519.6K
34.7K
Earning Date
05-01-2026
05-12-2026
Dividend Yield
0.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$357,854,000.00
N/A
Revenue This Year
$7.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.08
N/A
52 Week Low
$9.67
$1.70
52 Week High
$17.35
$25.00

Technical Indicators

Market Signals
Indicator
SHEN
YDES
Relative Strength Index (RSI) 55.19 48.98
Support Level $10.94 $1.93
Resistance Level $13.44 $2.93
Average True Range (ATR) 0.68 0.32
MACD 0.31 0.04
Stochastic Oscillator 82.50 48.84

Price Performance

Historical Comparison
SHEN
YDES

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: